Pharmaceuticals/Chemicals
Eplerenone (Inspra)
Also called Eplerenone · Inspra
Eplerenone comes up in bodybuilding discussions for water retention, blood pressure and hoped-for heart or kidney protection during steroid use. Its specific action is blocking aldosterone, a hormone involved in salt balance. The practical trade-off is potassium: it can rise, especially when other cardiovascular medicines are involved.
Dosage & duration
US Inspra label · adult starting treatment depends on the indication
Post-heart-attack HFrEF
Product label- Dose
- 25 mg per dose initially
- How often
- Once daily by mouth
- How long
- Ongoing treatment with laboratory-guided review
The label aims toward 50 mg daily within 4 weeks if tolerated; potassium changes can require a different plan.
Sources: 1
Hypertension
Product label- Dose
- 50 mg per dose initially
- How often
- Once daily by mouth
- How long
- Response reassessed over several weeks
Higher or split dosing is a clinician decision; renal function, potassium and interacting drugs can change eligibility and dose.
Sources: 1
These are named label contexts, not a plan to manage steroid-related water retention. A lower plotted peak does not guarantee safe potassium.
The bloat and blood-pressure questions
Swelling, blood pressure and potassium
-
Identify the cause
A puffy appearance alone does not explain why fluid is being retained.
-
A different hormone target
Eplerenone blocks aldosterone signaling; it does not replace an aromatase inhibitor.
-
Potassium and kidneys
Potassium can rise, especially with telmisartan, other relevant medicines or potassium products.
Why do bodybuilders discuss eplerenone?
Some bodybuilders consider it for water retention they attribute to GH or anabolic use, or for cardiovascular concerns alongside medicines such as telmisartan. Some users also compare it with spironolactone because of receptor selectivity. These are the reasons for interest; reported experiences are mixed.
Is this an estrogen-control drug?
No. Eplerenone blocks the action of aldosterone, a hormone involved in salt and fluid balance. An aromatase inhibitor acts on estrogen production. A puffy appearance does not tell you which pathway is responsible, so adding a diuretic is not a substitute for identifying the cause of new swelling.
How does it compare with telmisartan?
Both appear in blood-pressure discussions, but they act at different points: telmisartan blocks an angiotensin receptor, while eplerenone blocks aldosterone signaling. Their combination can increase potassium risk and needs a specific clinical reason and monitoring. Adding another medicine when BP is already low-normal is not automatically extra protection.
What about preventing steroid heart damage?
Eplerenone has clinical outcome evidence in selected heart-failure patients. That does not establish prevention of steroid-related heart or kidney injury in otherwise healthy lifters. Blood-pressure readings are useful, but cannot answer every question about cardiovascular health.
What is the most useful follow-up?
Potassium and kidney-function testing, together with BP readings and a medication review. The label calls for potassium testing before starting, within the first week and at one month after starting or adjusting treatment. Treatment duration depends on the condition being treated.
Model details: Eplerenone (Inspra) · estimated
How to read this estimate
Estimated from study endpoints; the curve between measurements is reconstructed. Compare amounts and timing in mg.
Reconstructs the fasting INSPRA tablet study; it does not predict blood-pressure or potassium response.
Assumptions, calculation and sources
INSPRA 50 mg oral tablet (Pfizer Canada), fasted single dose. Oral. 24 healthy adult participants in the monograph bioequivalence analysis.
eplerenone parent: estimated concentration in plasma (ng/mL).
One fasting INSPRA 50 mg reference arm: mean terminal half-life 4.56 h and median peak time 1.75 h.
- Calibration dose
- 50 mg
- Reported calibration peak
- 1281.72 ng/mL
- Peak timing used
- 1.75 hours
- Terminal half-life used
- 4.56 hours
- Reconstructed absorption rate
- 1.434773 /hour
- The observed peak already incorporates oral availability; do not multiply by the separately reported 69% bioavailability.
- Mean peak and terminal half-life plus median peak timing summarize a population; this is not an individual fitted profile.
- Linear dose scaling and dose superposition are approximations. The US label describes dose-proportional exposure at 25–100 mg, not unrestricted proportionality.
- Predicted AUC∞ is 11001.69 ng·h/mL, about 9.9% above the reference-arm mean 10009.82; matching peak/timing does not reproduce every exposure metric.
- Kidney/liver function, heart failure and CYP3A interactions can change exposure or safety. The model does not choose a potassium threshold, dose or blood-pressure target.
- Health Canada — JAMP Eplerenone monograph, comparative bioavailability
Page 27 reference INSPRA 50 mg arm, fasting single-dose crossover, 24 healthy adults: arithmetic Cmax 1281.72 ng/mL, median Tmax 1.75 h, arithmetic half-life 4.56 h, arithmetic AUC∞ 10009.82 ng·h/mL. Test-product values and geometric means are not used.
- DailyMed — Inspra (eplerenone) label
US label revised June 2025: adult hypertension and stable post-MI symptomatic HFrEF; indication-specific starting doses, potassium/renal monitoring, CYP3A and potassium-related interactions. Dose proportionality 25–100 mg; timing 3–6 h half-life and 1.5–2 h peak.
Estimate eplerenone-inspra-fasting-estimate-2026-10 · version 1
Safety and interaction notes Read the limitations and discuss clinical questions with a professional
High potassium and renal-function changes require monitoring. Strong CYP3A inhibitors are contraindicated; additional restrictions depend on the indication.
Common questions
Why do lifters mention eplerenone for bloat?
The reported rationale is aldosterone blockade and its role in salt balance. Community discussions include GH- or testosterone-associated water retention, but a swollen or puffy appearance does not diagnose the cause.
Is it an alternative to Arimidex or Aromasin?
It acts on a different pathway. Eplerenone blocks aldosterone; aromatase inhibitors reduce estrogen production. They are not interchangeable treatments for a symptom.
Can it be combined with telmisartan?
The combination is sometimes used for a clinical indication, but the Inspra label warns that ARBs increase hyperkalemia risk. Potassium, kidney function and blood pressure need review; it is not an automatic on-cycle combination.
Why compare it with spironolactone?
Some people are interested in its receptor selectivity. The eplerenone label describes preferential binding to mineralocorticoid receptors over androgen and progesterone receptors; that does not remove its potassium or kidney-related risks.
Is 25 mg a standard bodybuilding amount?
There is no source-verified bodybuilding regimen in this guide. The visible 25 mg and 50 mg examples come from different US label indications, with laboratory-guided adjustments.
Sources Labels, studies and notes behind this guide
Catalog evidence: Human clinical trials. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-09. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Why lifters look at it
- These are documented discussion topics, not proof that every case of steroid-related swelling has the same cause.
- How it is different
- It acts on salt-balance signaling; it does not replace an aromatase inhibitor for an estrogen-related problem.
- What changes the decision
- Especially relevant when telmisartan, other RAAS medicines or potassium products are already in the picture.
- 1. DailyMed — Inspra (eplerenone) label
US label revised June 2025: adult hypertension and stable post-MI symptomatic HFrEF; indication-specific starting doses, potassium/renal monitoring, CYP3A and potassium-related interactions. Dose proportionality 25–100 mg; timing 3–6 h half-life and 1.5–2 h peak.
- 2. Health Canada — JAMP Eplerenone monograph, comparative bioavailability
Page 27 reference INSPRA 50 mg arm, fasting single-dose crossover, 24 healthy adults: arithmetic Cmax 1281.72 ng/mL, median Tmax 1.75 h, arithmetic half-life 4.56 h, arithmetic AUC∞ 10009.82 ng·h/mL. Test-product values and geometric means are not used.
- 3. NHS — about eplerenone
Patient-facing explanation of aldosterone blockade, heart-failure treatment and the need for potassium blood tests.
Related compounds and examples
Related compounds
Nebivolol
Nebivolol treats high blood pressure and slows the heart’s response to stimulation. Lifters research it for elevated resting heart rate or blood pressure, but improving those numbers does not make steroid or stimulant exposure harmless.
Telmisartan
Telmisartan treats high blood pressure. In PED discussions it is often called heart or kidney protection, but that shorthand goes too far: it can address a real blood-pressure problem without cancelling all the risks of a steroid regimen.
Estradiol Topical (EstroGel)
Estradiol gel is used to ease menopausal hot flushes and other low-estrogen symptoms without a pill or injection. The practical choices are the exact pump product, the daily skin routine and whether a separate progestogen is needed.